top of page
Browse by category
Search
Considerations when moving from laparoscopic to robotic assisted bariatric surgery
At the recent IFSO-EC meeting in Venice, Italy, Medtronic hosted an intriguing lunch time symposium that examined the technical and...
BOMSS changes name to include all obesity specialists
Bariatric News spoke with Professor Ahmed Ahmed (Associate Professor in Metabolic Surgery and Lead Bariatric Surgeon at Imperial College...
Ring-augmented RYGB in patients with BMI≥50 leads to significant weight loss and improvement in obesity-related complications
Ring-augmented RYGB (raRYGB) with a MiniMizer Ring in patients with BMI≥50kg/m2, results in significant weight loss and improvements in...
International expert consensus statements on surgery for T2DM
An International panel of experts has published 43 statements on the nature, terminology and mechanisms of action of metabolic and...
Only one in 12 remain on a GLP-1 drug for obesity at three years
Only 8% of individuals (or one in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to...
Robotic outcomes comparable with laparoscopic bariatric surgery
The number of robotic MBS procedures in Australia has risen over the years but the proportion of surgeons performing them remain...
Injectable medications for obesity produce smaller weight loss in a real-world setting, compared to randomised clinical trials
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in a...
Society of Obesity and Bariatric Anaesthesia publishes 43 recommendations to improve the safety and efficacy of airway management in patients living with obesity
The UK’s Society of Obesity and Bariatric Anaesthesia (SOBA) has published 43 recommendations which cover a number of key areas of...
Combination of weight loss drugs better for pre-BMS patients than GLP-1s or dieting alone
A study by Pennington Biomedical Research Center's Metamor Institute researchers that evaluated the use of different types of pre-surgery...
GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...
Browse by tag
bottom of page